Brief: Shanghai Jiaoda Onlly gets approval to acquire stake in China NT Pharma
Sept 6 (Reuters) - Shanghai Jiaoda Onlly Co Ltd 600530.SS
* Says it gets approval from Shanghai municipal commission
of commerce to acquire 7.38 percent stake in China NT Pharma for
HK$288.66 million ($37.22 million)
Source text in Chinese: http://bit.ly/2c2unjH
Further company coverage: 600530.SS
($1 = 7.7553 Hong Kong dollars)
(Reporting by Hong Kong newsroom)
((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441;
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY